The Albumin Human, cataloged under National Stock Number 6505-01-562-3680, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Kedrion Biopharma Inc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-562-3680 |
| Primary Part Number | NDC76125-0790-25 |
| Item Name | Albumin Human |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Kedrion Biopharma Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 250.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Active Medicament Medicinal Strength | 5.000 PERCENTAGE, W/V ALBUMIN, NORMAL HUMAN SERUM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC68516-5214-01 | Dms Pharmaceutical Group Inc (USA) |
| NDC76125-0790-25 PRIMARY | Kedrion Biopharma Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC68516-5214-01 | 5/9 Secondary reference Bdi Pharma, Inc. |
| ALBUKED | 5/1 Secondary reference Kedrion Biopharma Inc |
| ALBUTEIN | 5/9 Secondary reference Bdi Pharma, Inc. |
| NDC68516-5214-01 | 5/9 Secondary reference Grifols Biologicals Llc |
NSN 6505-01-562-3680 is a Albumin Human, manufactured by Kedrion Biopharma Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-562-3680 has 2 manufacturer part numbers on file: NDC68516-5214-01 (Dms Pharmaceutical Group Inc), NDC76125-0790-25 (Kedrion Biopharma Inc).
Key specifications for NDC76125-0790-25: Primary Container Content Quantity: 250.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL; Special Features: 5 PCT. ALBUMIN;HEAT TREATED; 250 ML RUBBER-STOPPERED VIAL; ADMINISTRATION SETS NOT INCLUDED; ADMINISTRATION SET IS AVAILABLE UPON REQUEST BY THE BRIFOLS COMPANY; USE IN TREATMENT OF SHOCK ASSOCIATES W/SURGERY, TRAUMA, BURNS, BACTEREMIA, RENAL FAILURE, AND CARDIOVASCULAR COLLAPSE. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.